Real-World Clinical Effectiveness of Loncastuximab Tesirine Monotherapy for the Treatment of Relapsed/ Refractory Diffuse Large B-cell Lymphoma Following Chimeric Antigen T- Cell Therapy in the US

被引:0
作者
Epperla, Narendranath [1 ]
Lucero, Melanie [2 ]
Bailey, Tom [3 ]
Mirams, Laura [3 ]
Cheung, Jolenta [3 ]
Amet, Mona [3 ]
Milligan, Gary [3 ]
Keir, Chris [4 ]
Chen, Lei [5 ]
机构
[1] Ohio State Univ, Columbus, OH USA
[2] ADC Therapeut Amer Inc, New Providence, NJ USA
[3] Adelphi Real World, Macclesfield, Cheshire, England
[4] ADC Therapeut, Murray Hill, NJ USA
[5] ADC Therapeut, New Providence, NJ USA
关键词
loncastuximab tesirine; CD19-targeted chimeric antigen receptor T-cell therapy; real-world evidence; treatment sequencing;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ABCL-370
引用
收藏
页码:S476 / S476
页数:1
相关论文
empty
未找到相关数据